Fiche société
UCB BIOSCIENCES, Inc.
Traitements, essais et publications liés.
Traitements2programmes
Essais3liés
Publications5liées
SourceDBlocale
Traitements
2| Molécule | Indication / population | Phase | Objectif | Pays | Résultat |
|---|---|---|---|---|---|
| LacosamideEP0060 is a multicenter, open-label study to evaluate the safety and tolerability of intravenous (iv) Lacosamide (LCM) in pediatric subjects \>= 1 month to \< 17 years of age with epilepsy. | Épilepsie | Phase 2 | À vérifier | United States, Hungary, Italy, Poland, Ukraine | À vérifier |
| LacosamideEP0060 is a multicenter, open-label study to evaluate the safety and tolerability of intravenous (iv) Lacosamide (LCM) in pediatric subjects \>= 1 month to \< 17 years of age with epilepsy. | Épilepsie | Phase 2 | À vérifier | United States, Hungary, Italy, Poland, Ukraine | À vérifier |
Essais cliniques
3| Molécule | Indication / population | Phase | NCT | Titre | Statut |
|---|---|---|---|---|---|
| doxecitine and doxribtimine | Myopathies | Phase 2 | NCT03845712 | An Open-Label Study of Continuation Treatment With Combination Pyrimidine Nucleosides in Patients With TK2 Deficiency | COMPLETED |
| fenfluramine | Épilepsie | Phase 3 | NCT06118255 | ORCHID — A Study to Evaluate Safety, Tolerability, and Pharmacokinetics of Fenfluramine (Hydrochloride) in Infants 1 Year to Less Than 2 Years of Age With Dravet Syndrome | COMPLETED |
| Lacosamide | Épilepsie | Phase 2 | NCT02710890 | ASPIRE — Study to Investigate Safety and Tolerability of Intravenous Lacosamide in Children. | COMPLETED |
Publications
5| Molécule | Indication / population | Titre | Journal | Date |
|---|---|---|---|---|
| Lacosamide | Clinical drug-oriented design, synthesis, and pharmacological evaluation of novel dual-target antiepileptic hybrid molecules. | Bioorganic chemistry | ||
| Lacosamide | Lacosamide Use After Traumatic Brain Injury: A Scoping Review. | Cureus | ||
| Lacosamide | Retrospective, Multicenter Study of Lacosamide to Treat Neonatal Seizures. | Annals of the Child Neurology Society | ||
| Lacosamide | Lacosamide and Increased Fracture Risk: Need for More Study of Antiseizure Medications and Bone Health. | Neurology | ||
| Lacosamide | Fracture Risk With Lacosamide vs Levetiracetam Monotherapy in Adults With Epilepsy. | Neurology |